Each year, Midwest Real Estate News inducts a new class into its Midwest Commercial Real Estate Hall of Fame. Today we look at the busy career of Michael Mullady, executive vice president with the Columbus, Ohio, office of CBRE.
During a 20-year career with CBRE, Columbus-based CRE veteran Michael Mullady has negotiated more than 60 million square feet in sale and lease transactions. These transactions have totaled more than $1 billion.
With numbers like that, it’s not shocking that Mullady has developed a reputation as one of the top-performing CRE practitioners in the Columbus region.
His long list of industry awards offers additional proof: From 2010 through 2017, Mullady ranked among the top 20 percent of national producers with CBRE; in 2010, he ranked as CBRE’s top U.S. industrial broker; in 2006 and from 2009 through 2017, he was selected for the commercial Top Producer award from the Columbus Board of Realtors; and in 2016, he earned the NAIOP Chicago Industrial Transaction of the Year honor.
During his long career, Mullady has closed several big transactions. This includes a deal with Mars, Inc., that totaled more than 10 million square feet, and another with Pier 1 for more than 2.09 million square feet. Mullady also closed a deal for McGraw Hill Companies for 1.94 million square feet, Quaker Sales & Distribution for 1.4 million square feet and Restoration Hardware for 1.2 million square feet.
When not working, Mullady has donated his time to his community. He has worked closely with Ronald McDonald House Charities and recently donated a recreation room to the new Columbus Ronald McDonald House. Patients of Nationwide Children’s Hospital and their families can relax and play games in this space during their stay at the hospital.
In his rare free time, Mullady prefers spending time outside. He is an avid outdoorsman and a passionate conservationist, teaming with Ducks Unlimited, a nonprofit dedicated to preserving wetlands and other habitats for water fowl. Mullady also works with Special Olympics and the Leukemia and Lymphoma Society.